Module information

Module details

Title
Pathological Basis of Disease
Type
Specialist
Module code
S-H-S2
Credits
10
Phase
2
Requirement
Compulsory

Aim of this module

This module aims to provide the trainee with knowledge and understanding of the pathological basis of disease and the use of histopathology, cytopathology, immunohistochemistry and molecular pathology techniques to detect, diagnose and monitor disease in patient samples. Trainees will apply a range of techniques to case studies in clinical practice and gain experience of interpreting results as part of patient investigations.

Work-based content

Training activities

# Learning outcome Training activity Type Action
# 1 Learning outcome 1,9 Training activities

Prepare representative patient samples from a range of tissue types and identify the following types of inflammatory processes:

  • Acute inflammation
  • Chronic inflammation
  • Granulomatous inflammation
Type ETA Action View
# 2 Learning outcome 2,9 Training activities

Prepare representative patient samples from a range of tissue types and identify three of the following processes:

  • Hypoplasia
  • Hyperplasia
  • Hypertrophy
  • Necrosis
  • Apoptosis
  • Atrophy
  • Degenerative disease
Type ETA Action View
# 3 Learning outcome 3,9 Training activities

Prepare representative patient samples from a range of tissue types and identify the following processes:

  • Tissue and cell injury
  • Healing and repair
  • Thrombosis
  • Embolism
  • Atherosclerosis
  • Oedema
  • Ischaemia
  • Infarction
Type ETA Action View
# 4 Learning outcome 4,9 Training activities

Prepare representative patient samples from a range of tissue types, identify the presence and pathological manifestation of infections caused by the following:

  • Bacteria
  • Viruses
  • Fungi
  • Parasites
Type ETA Action View
# 5 Learning outcome 5,9 Training activities

Prepare representative patient samples from a range of tissue types and identify the immune response and immunological disease in two of the following:

  • Normal immune system
  • Primary or secondary immunodeficiency
  • Autoimmune disease
  • Transplant rejection
Type ETA Action View
# 6 Learning outcome 6,9 Training activities

Using representative patient samples from a range of tissue types, with a consultant supervisor identify the following processes:

  • Metaplasia
  • Dysplasia
  • Malignancy
  • Metastasis
Type DTA Action View
# 7 Learning outcome 7,9 Training activities

Decalcify a benign specimen and perform an ‘end of decalcification’ test

Type ETA Action View
# 8 Learning outcome 1,2,3,4,5,6,8,9 Training activities

In relation to non-malignant disease; capture, annotate and describe:

  • macroscopic images
  • microscopic images
Type DTA Action View
# 9 Learning outcome 5,6,9 Training activities

Perform microtomy of a specimen for onward molecular testing

Type ETA Action View

Assessments

Complete 2 Case-Based Discussions

Complete 2 DOPS or OCEs

Direct Observation of Practical Skills Titles

  • Perform microscopical assessment of stained slides to identify different types of inflammation.
  • Perform microscopical assessment of stained slides to identify tissues undergoing proliferation or degeneration.
  • Perform microscopical assessment of stained slides to identify tissue injury and repair.
  • Perform microscopical assessment of stained slides to identify the presence of infectious organisms.
  • Perform microscopical assessment of stained slides to identify the presence of an immunological response and disorders of the immune system.
  • Perform microscopical assessment of stained slides to identify metaplasia or dysplasia.
  • Perform microscopical assessment of stained slides to identify malignancy and metastasis.

Observed Communication Event Titles

  • Discuss a case with a Consultant Pathologist or Consultant Scientist and suggest additional investigative techniques to determine a diagnosis.
  • Discuss a case for reporting to a screening programme with a Consultant Pathologist or Consultant Scientist and identify appropriate follow up from screening guidance.

Learning outcomes

# Learning outcome
1

Use histological techniques to demonstrate the different types of inflammation.

2

Use histological techniques to demonstrate the different types of benign proliferation and degeneration.

3

Use histological techniques to demonstrate the different types of injury, repair and vascular damage.

4

Use histological techniques to demonstrate the different types of infection.

5

Use histological techniques to demonstrate the different types of immunological disease.

6

Use histological techniques to demonstrate the different types of abnormal proliferation.

7

Apply decalcification techniques to minimise the impact on downstream testing.

8

Employ techniques to capture, annotate and describe macroscopic and microscopic images of non-malignant pathologies.

9

Practice safely in accordance with quality management and accreditation standards.

Clinical experiences

Clinical experiences help you to develop insight into your practice and a greater understanding of your specialty's impact on patient care. Clinical experiences should be included in your training plan and you may be asked to help organise your experiences. Reflections and observations from your experiences may help you to advance your practice and can be used to develop evidence to demonstrate your awareness and appreciation of your specialty.

Activities

  1. Attend a multidisciplinary team meeting relating to a case where they have been involved in its pathway through the laboratory to appreciate the role of histopathology in patient management.
  2. Attend a clinic where histopathological samples are taken to appreciate the patient experience e.g. endoscopy, dermatology or colposcopy.
  3. Attend a clinic where diagnostic cytology samples are taken to appreciate the patient experience, e.g. EUS, EBUS or FNA.
  4. Attend a meeting where genomic information is discussed to appreciate the role of molecular pathology in patient management.
  5. Attend a morbidity and mortality meeting to appreciate the input of histopathology.

Academic content (MSc in Clinical Science)

Important information

The academic parts of this module will be detailed and communicated to you by your university. Please contact them if you have questions regarding this module and its assessments. The module titles in your MSc may not be exactly identical to the work-based modules shown in the e-portfolio. Your modules will be aligned, however, to ensure that your academic and work-based learning are complimentary.

Learning outcomes

On successful completion of this module the trainee will be able to:

  1. Evaluate systemic and local disease within major organ systems with a focus on benign pathologies.
  2. Summarise the mechanisms and microscopic appearances of benign tissue pathologies and discuss the specific roles of regenerative, inflammatory and infectious processes and the immune response.
  3. Outline the autopsy process and evaluate underlying principles of consent, ethical and regulatory issues.

Indicative content

  • Normal appearance of a variety of organ systems, including skin, gastrointestinal, breast, male and female genital tracts and the urinary systems.
  • Principles of inflammation, benign proliferation and degeneration, injury, repair and vascular damage, infection, immunological disease and abnormal proliferation.
  • Aetiology, epidemiology and the main clinical features of common, benign disorders.
  • Knowledge of autopsies and the underlying principle of consent, and ethical and regulatory issues.
  • Relate genomics and bioinformatics to the clinical investigation.
  • Methods and relevance of decalcification techniques.

Module assigned to

Specialties

Specialty code Specialty title Action
Specialty code SLS3-4-22 Specialty title Histopathology [2022] Action View
Specialty code SLS3-4-23 Specialty title Histopathology [2023] Action View
Specialty code SLS3-4-24 Specialty title Histopathology [2024] Action View